1 option
CDEC final recommendation : indication : HIV infection. Dolutegravir (Tivicay -- ViiV Healthcare ULC) / CADTH Canadian Drug Expert Committee.
- Format:
- Book
- Author/Creator:
- CADTH Canadian Drug Expert Committee, author, issuing body.
- Language:
- English
- Subjects (All):
- Outcome assessment (Medical care).
- Outcome assessment (Medical care)--Methodology.
- Physical Description:
- 1 online resource
- Place of Publication:
- Ottawa, ON : Canadian Agency for Drugs and Technologies in Health, 2014.
- Summary:
- The Canadian Drug Expert Committee (CDEC) recommends that dolutegravir be listed for the treatment of HIV in both treatment-naive and treatment-experienced adults and children 12 years of age and older weighing at least 40 kg.
- Notes:
- Description based on publisher supplied metadata and other sources.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.